Table 2 Results of the enzyme-linked immunosorbent assay to assess coagulation function, platelet activation, and systemic inflammation.
PPP | PPP + H12 | PRP | PRP + H12 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
preCPB | postCPB | post T/F | preCPB | postCPB | post T/F | preCPB | postCPB | post T/F | preCPB | postCPB | post T/F | |
ELISA | ||||||||||||
Fibrinogen (mg/dL) | 623 ± 322 | 193 ± 59 | 301 ± 54 | 701 ± 218 | 124 ± 46 | 284 ± 48 | 869 ± 391 | 224 ± 103 | 368.0 ± 102 | 909 ± 371 | 295 ± 99 | 330 ± 99 |
β-TG (ng/mL) | 141 ± 22 | 110 ± 2 | 131 ± 18 | 135 ± 23 | 120 ± 13 | 117 ± 9 | 118 ± 135 | 112 ± 9 | 99 ± 11 | 110 ± 10 | 141 ± 22 | 82 ± 10 |
PF4 (ng/mL) | 1.8 ± 0.3 | 3.9 ± 1.0 | 3.2 ± 1.5 | 2.8 ± 0.5 | 5.2 ± 1.3 | 4.3 ± 1.9 | 2.0 ± 0.5 | 4.5 ± 0.8 | 3.0 ± 0.6 | 2.4 ± 1.3 | 4.3 ± 1.4 | 2.9 ± 1.2 |
IL-6 (ng/mL) | 0 ± 0 | 54.0 ± 5.4 | 108 ± 27.4 | 0 ± 0 | 99.8 ± 53.8 | 104.8 ± 67.0 | 0 ± 0 | 76.8 ± 44.9 | 92.1 ± 62.7 | 0 ± 0 | 53.6 ± 11.1 | 69.8 ± 15.9 |
